Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06566053

Establishment of a Predictive System for Perioperative Risk Assessment and Electronic Flowcharting Response Strategies in Thoracic Surgery

1. To establish a risk assessment scale for thoracic surgery for the Chinese population, and to classify patients; risk according to the relevant scale; 2. Combining the guidelines for the management of acute and critical illnesses in thoracic surgical care units and the characteristics of diagnosis and treatment operations, to make an AI-assisted diagnosis and treatment process software; 3. Evaluate whether the software can provide timely and correct diagnosis and treatment recommendations for critically ill patients, shorten the time for homogenized training of specialist intensivists, and reduce the hospitalization cost of patients under the review of resident training instructors of various specialties.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

the Second Xiangya Hospital of Central South University

Changsha, Hunan, 410011, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admitted to the Department of Thoracic Surgery of the Second Xiangya Hospital of Central South University for surgical treatment.

Exclusion criteria

  • Patients admitted to the Department of Thoracic Surgery of the Second Xiangya Hospital of Central South University without surgical treatment.

Patients under the age of 18.

Treatment and study plan

observation

Other

Observation

Primary outcomes

  1. Acute Respiratory Distress Syndrome

    Time frame: 2024.8-2024.12

    ARDS definition was based on the new global definition of ARDS10. Briefly, intubated ARDS was defined as an oxygenation index of less than 300 under a positive end-expiratory pressure (PEEP) of at least 5 cmH2O, and non-intubated ARDS was defined as patients receiving high-flow nasal oxygen (HFNO) ≥ 30 L/min or noninvasive ventilation/continuous positive airway pressure (NIV/CPAP) with a PEEP of at least 5 cmH2O and meeting PaO2:FiO2 ≤ 300 mm Hg or SpO2:FiO2 ≤ 315 (if SpO2 ≤ 97%).

Secondary outcomes

  1. In hospital mortality

    Time frame: 2024.8-2024.12

    refers to the number or percentage of patients who die while being treated in a hospital.

  2. Length of hospital stay

    Time frame: 2024.8-2024.12

    Length of hospital stay(days): refers to the total number of days a patient spends in the hospital from the time of admission to the time of discharge.

  3. Length of ICU stay

    Time frame: 2024.8-2024.12

    Length of ICU stay(hours): refers to the total duration of time a patient spends in the Intensive Care Unit (ICU) during a single admission.

  4. Length of postoperative stay

    Time frame: 2024.8-2024.12

    Length of postoperative stay(days): refers to the duration of time a patient remains in the hospital or medical facility after undergoing surgery.

  5. Duration of mechanical ventilation

    Time frame: 2024.8-2024.12

    Duration of mechanical ventilation(hours): refers to the length of time a patient requires assistance from a mechanical ventilator to maintain adequate breathing.

  6. Duration of HFNC

    Time frame: 2024.8-2024.12

    Duration of HFNC(hours): refers to the length of time that a patient is treated with High-Flow Nasal Cannula (HFNC) therapy.

Sponsors and collaborators

Lead sponsor

Hengxing Liang

Other

Collaborators

  • Changsha Xinghong Network Technology Co.

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2027
First posted
Aug 22, 2024
Registry last updated
Aug 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.